Study To Assess Effectiveness and Adverse Events of Foscarbidopa/ Foslevodopa in Adult Participants With Advanced Parkinson Disease in Real Life Setting
Clinical trial NCT06639620 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06639620
- Sponsor
- AbbVie
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-11-12
- Primary completion
- 2027-03-01
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.